Article

PubChem as a public resource for drug discovery

National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD 20894, USA.
Drug discovery today (Impact Factor: 6.69). 10/2010; 15(23-24):1052-7. DOI: 10.1016/j.drudis.2010.10.003
Source: PubMed

ABSTRACT

PubChem is a public repository of small molecules and their biological properties. Currently, it contains more than 25 million unique chemical structures and 90 million bioactivity outcomes associated with several thousand macromolecular targets. To address the potential utility of this public resource for drug discovery, we systematically summarized the protein targets in PubChem by function, 3D structure and biological pathway. Moreover, we analyzed the potency, selectivity and promiscuity of the bioactive compounds identified for these biological targets, including the chemical probes generated by the NIH Molecular Libraries Program. As a public resource, PubChem lowers the barrier for researchers to advance the development of chemical tools for modulating biological processes and drug candidates for disease treatments.

Download full-text

Full-text

Available from: Yanli Wang
  • Source
    • "Our method for calculating the drug chemical structure similarity SIM chem (d x , d y ) is based on the 2D chemical fingerprint descriptor of each drug's chemical structure in PubChem (Wang et al., 2009; Li et al., 2010). That is, each drug is represented by a binary fingerprint f (d x ) in which each bit indicates the presence of a predefined chemical structure fragment. "

    Preview · Article · May 2015 · Data Science Journal
  • Source
    • "The two dimensional structures of all four compounds were shown in Figure.1 [14]. The molecular properties of these compounds were tabulated in Table. 1 [14]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Antibiotics resistant Staphylococcus aureus (S. aureus) is an emerging concern in the medical field. Due to their increasing resistance to numerous antibiotics, there is indeed essential to explore both potential targets and effective antibiotics. Therefore, we considered undecaprenyl diphosphate synthase (UPPS) as a potential target as it is an essential enzyme in cell wall biosynthesis of S. aureus. Earlier reports on these four major compounds from Camellia sinensis plant extract such as catechins (C), epicatechin (EC), epicatechin gallate (ECg) and epigallocatechin gallate (EGCg) suggested that it could be an effective antibacterial agent. Thus, we attempt to validate the antibacterial activity of these compounds against UPPS via molecular docking analysis. Interestingly, we found that epicatechin gallate (ECg) has the highest binding energy with UPPS protein by forming nine hydrogen bonds with the amino acid residues at the binding site of the receptor. Hence, our results infer that ECg from Camellia sinensis poses significant anti-bacterial activities. Thus, the aim of this study was to provide an effective antibacterial molecule and potent target which might be helpful in further modification to increase their sensitivity.
    Full-text · Article · Sep 2014
  • Source
    • "Molecular docking analysis of the modeled protein structures was carried out to identify if substitutions in the amino acid sequences of blaA resulted in variations in their binding affinity to β-lactam antibiotic amoxicillin and the β-lactamase inhibitor clavulanic acid. The structures of amoxicillin and clavulanic acid were retrieved from the PubChem compound database (http://pubchem.ncbi.nlm.nih.gov/)28. Subsequently the downloaded SDF file was converted to PDB format using iBabel. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Beta-lactams are used as major therapeutic agents against a number of infectious agents. Due to widespread use of β-lactams, β-lactamases have evolved at a rapid pace leading to treatment failures. Yersinia enterocolitica causes many gastrointestinal problems. It is an extremely heterogeneous species comprising more than fifty serotypes and six biotypes which differ in their ecological niches, geographical distribution and pathogenic potential. Though biotype 1A strains have been associated with outbreaks of Yersiniosis, there has been a controversy regarding their pathogenicity. The strains of Y. enterocolitica isolated from India belonged to biotype 1A and possessed genes for two β-lactamases namely, blaA and blaB. An earlier study by us reported differential expression of blaA by strains of Y. enterocolitica biotype 1A. The present study has been carried out to understand the molecular bases which regulate the expression of blaA in Y. enterocolitica biotype 1A. We concluded that six types of blaA variants were present in strains of biotype 1A. Neither amino acid substitutions in blaA nor mutations in promoter regions of blaA contributed to differential expression of blaA in Y. enterocolitica biotype 1A. Rather, the secondary structures attained by mRNA of blaA might underlie the differential expression of blaA in Y. enterocolitica.
    Full-text · Article · Jun 2014 · Scientific Reports
Show more